Literature DB >> 26972083

Correlation of Anti-mitochondrial Antibodies with Liver Histology and Outcomes.

Susanna Tan1, Zohreh Movahedi1, Jill Beisel1, Napatkamon Ayutyanont2, Abdul Nadir3,4.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26972083     DOI： 10.1007/s10620-016-4094-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates.

Authors:  Paola Loria; Amedeo Lonardo; Francesca Leonardi; Cristina Fontana; Lucia Carulli; Anna Maria Verrone; Andrea Borsatti; Marco Bertolotti; Fabio Cassani; Alberto Bagni; Paolo Muratori; Dorval Ganazzi; Francesco B Bianchi; Nicola Carulli
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

2.  Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease.

Authors:  Sujan Ravi; Mohamed Shoreibah; Evan Raff; Joseph Bloomer; Donny Kakati; Khalid Rasheed; Ashwani K Singal
Journal:  Dig Dis Sci       Date:  2015-07-15       Impact factor: 3.199

3.  Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network.

Authors:  Raj Vuppalanchi; Robert J Gould; Laura A Wilson; Aynur Unalp-Arida; Oscar W Cummings; Naga Chalasani; Kris V Kowdley
Journal:  Hepatol Int       Date:  2011-05-10       Impact factor: 6.047

4.  Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis.

Authors:  Saeko Nezu; Atsushi Tanaka; Hideaki Yasui; Makiko Imamura; Hiroshi Nakajima; Hitoshi Ishida; Shin-Ichi Takahashi
Journal:  J Gastroenterol Hepatol       Date:  2006-09       Impact factor: 4.029

Review 5.  Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature.

Authors:  M Ramos-Casals; A Pares; L-J Jara; R Solans; O Viñas; P Vázquez; J-M Sánchez-Tapias; J Rodés; J Font
Journal:  J Viral Hepat       Date:  2005-11       Impact factor: 3.728

6.  Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?

Authors:  Wei-Hong Yang; Jiang Hong Yu; Ayako Nakajima; Donna Neuberg; Keith Lindor; Donald B Bloch
Journal:  Clin Gastroenterol Hepatol       Date:  2004-12       Impact factor: 11.382

7.  Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?

Authors:  H C Mitchison; M F Bassendine; A Hendrick; M K Bennett; G Bird; A J Watson; O F James
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

Review 8.  Primary biliary cirrhosis.

Authors:  Elizabeth J Carey; Ahmad H Ali; Keith D Lindor
Journal:  Lancet       Date:  2015-09-11       Impact factor: 79.321

9.  Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis.

Authors:  Scott J Cotler; Kiran Kanji; Ali Keshavarzian; Donald M Jensen; Shriram Jakate
Journal:  J Clin Gastroenterol       Date:  2004-10       Impact factor: 3.062

Review 10.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.